Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
申请人:——
公开号:US20040106602A1
公开(公告)日:2004-06-03
Compounds according to formula I:
1
wherein R
1
, R
2
, R
3
, R
4
, R
5
and n are as defined herein, are administered for the treatment of inflammatory disorders mediated by LTB
4
,